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The study aimed to investigate the phytochemical contents, antioxidant and antiproliferative activity of 80% methanol extract of
Lepidozia borneensis. The total phenolic and total flavonoid contents were analysed using Folin-Ciocalteu and aluminium chloride
colorimetric methods. Antioxidant properties were evaluated by using FRAP, ABTS, and DPPH assays while the effects of L.
borneensis on the proliferation ofMCF-7 cell line were evaluated by usingMTT assay.The results showed that the total phenolic and
flavonoid contents were 12.42 ± 0.47mg GAE/g and 9.36 ± 1.29mg CE/g, respectively.The GC-MS analysis revealed the presence of
at least 35 compounds. The extract was found to induce cytotoxicity against MCF-7 cell line with IC
50
value of 47.33 ± 7.37 𝜇g/mL.
Cell cycle analysis showed that the extract induced significant arrest at G
0
/G
1
at 24 hours of treatment. After 72 hours of treatment,
the proportion of cells in G
0
/G
1
and G
2
-M phases had decreased significantly as compared to their control. Apoptosis occurred
during the first 24 hours and significantly increased to 30.8% after 72 hours of treatment. No activation of caspase 3 was observed.
These findings suggest that L. borneensis extract has the potential as natural antioxidant and anticancer agents.
1. Introduction
Approximately 14.1 million new cancer cases and 8.2 million
deaths occurred in 2012 globally and the number of deaths
caused by cancer is likely to increase to 13.1 million by 2030
[1, 2]. In Malaysia, cancer is ranked fourth among diseases
that cause deaths [3]. According to the statistics by the
Malaysian Ministry of Health, the annual mortality rate for
cancer disease has reached more than 10% since 2006 [4].
More than 60% of currently used drugs for cancer treatment
are natural based products [5]. The United States National
Cancer Institute (NCI) has collected about 35,000 plants
and screened 114,000 natural products extracts for anticancer
studies [6].
Bryophytes have been commonly used as herbalmedicine
in China and India and among Native Americans since
ancient times [7]. Bryophytes possess high amounts of ter-
penoids, phenolics, glycosides, fatty acids, and some rare
aromatic compounds that might contribute to prevention
of cancer and other chronic illnesses [8, 9]. Liverworts, in
particular, have beenwidely use in traditionalmedicine.They
contain lipophilic mono-, sesqui-, and diterpenoids, aro-
matic compounds (bibenzyls, bisbibenzyls, benzoates, cin-
namates, long-chain alkyl phenols, naphthalenes, phthalides,
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and isocoumarins), and acetogenins which constitute the oil
bodies that contribute to the biological activities [9].There are
more than 700 terpenoids and 220 aromatic compounds of
liverworts that have been studied in terms of their biological
activities [10].
Various compounds isolated from liverworts have high
potential as chemotherapeutic agents. It has been reported
that marchantin A, isoriccardin C, riccardin B, plagiochin E,
andmarchantin C isolated fromReboulia hemisphaericawere
found to display cytotoxicity against EYFP-tubulinHeLa cells
with IC
50
values of 22.6𝜇mol/L, 42.2𝜇mol/L, 41.6 𝜇mol/L,
32.7 𝜇mol/L, and 23.2 𝜇mol/L, respectively [11]. Marchantin
A which was isolated from Marchantia emarginata subsp.
tosana was found to induce apoptosis in MCF-7 cells [12].
A macrocyclic bisbibenzyl, riccardin D, which was isolated
fromDumortiera hirsuta inhibited the proliferation of human
non-small-cell lung cancer (NSCLC) both in vitro and in vivo
and does not cause toxicity in normal mammalian cells [13].
So far, the chemical compounds and biological activities
of Lepidozia borneensis have not been extensively reported in
literature. Thus, this study was carried out to determine the
phytochemical constituents and investigate the antioxidants
and antiproliferative effects of a liverwort, L. borneensis.
2. Materials and Methods
2.1. PlantMaterial and Sample Preparation. Plant sample was
collected from Mount Kinabalu, Sabah, Malaysia. Voucher
specimen was identified and deposited into BORNEENSIS
Herbarium (BORH), Institute for Tropical Biology and Con-
servation, Universiti Malaysia Sabah, Kota Kinabalu, Sabah,
Malaysia. The young green shoots of the bryophytes sample
were cut using a pair of scissors, excluding the lower part
which is normally brown in colour. Plant samplewas carefully
cleaned and washed by using distilled water to remove the
contaminants. Sample was dried in the oven for two days at
40∘C [14]. The dried sample was ground into fine powder
using an electric blender.
2.2. Sample Extraction. Ground sample was extracted using
the method from Velioglu et al. [15] with slight modification.
A quantity of 0.1 g of sample was extracted using magnetic
stirrer at 200 rpm for 2 hwith 10mL of 80%methanol at room
temperature. The mixture was filtered through a filter paper.
The extract was used for the determination of phytochemicals
and antioxidant assessments. For antiproliferative analysis,
the extract was evaporated using rotary evaporator and
further freeze-dried using freeze-dryer.
2.3. Total Phenolic Content. Total phenolic content was
determined using Folin-Ciocalteu reagent as adapted from
Velioglu et al. [15] with modifications. An aliquot (100𝜇L)
of extract was mixed with 750𝜇L of Folin-Ciocalteu reagent
(previously diluted 10-fold with distilled water), vortexed,
and allowed to stand at room temperature for 5min. The
mixture was then added to 750 𝜇L of sodium bicarbon-
ate (60 g/L) solution. After 90min at room temperature,
absorbance was measured at 725 nm using spectrophotome-
ter (Thermo Fisher Scientific 1510). Standards of gallic acid
in the concentration ranging from 0 to 100 𝜇g/mL were run
with the test samples. Results were expressed asmg gallic acid
equivalent in 1 g of dried sample (mgGAE/g).
2.4. Total Flavonoid Content. The total flavonoid was mea-
sured according to method described by Zhishen et al. [16].
Briefly, 1mL of extract was mixed with 4mL of distilled
water and 0.3mL of 5% sodium nitrite solution. After 5min,
0.6mL of 10% aluminium chloride was added and allowed
to stand for 6min before 2mL of 1M sodium hydroxide was
added to the mixture. The reaction of flavonoid with sodium
nitrite and aluminium chloride produces coloured flavonoid-
aluminium complex that was measured using spectropho-
tometer at 510 nm. Standards of catechin in the concentration
ranging from 0 to 100 𝜇g/mL were run with the test samples.
Results were expressed as mg catechin equivalent in 1 g of
dried sample (mgCE/g).
2.5. GasChromatographyMass Spectroscopy. GC-MSanalysis
was done according to method described by Yong et al.
[4]. Crude extract of plant sample was analysed with gas
chromatography equippedwithmass spectrometry (GC-MS-
2010 Plus-Shimadzu). The column temperature was set to
50∘C for 4min before it was increased to 320∘C at the rate
of 7∘C/min and was then held for 20min. The injector
temperature was set at 280∘C (split mode with the ratio being
adjusted to 20 : 1, injection volume = 0.1 𝜇L). The flow rate
of the helium carrier gas was set to 1mL/min with total
run time of 60min. Mass spectra were obtained from the
rangem/z 40 to 700 and the electron ionization at 70 eV. The
chromatogram of the sample was identified by comparing
their mass spectra with the library data and the GC retention
time against known standards.
2.6. Antioxidant Assessment Parameters
2.6.1. FRAP (Ferric Reducing/Antioxidant Power) Assay. This
method was conducted according to Benzie and Strain [17]
with slight modifications. The working FRAP reagent was
produced by mixing 300mM acetate buffer (pH 3.6), 10mM
2,4,6-tripyridyl-s-triazine (TPTZ) solution, and 20mM ferric
chloride in a 10 : 1 : 1 ratio prior to use in water bath at 37∘C.
A total of 3mL FRAP reagent was added to a test tube and a
blank reading was taken at 593 nm using spectrophotometer.
A total of 100 𝜇L of selected plant extracts and 300 𝜇L of
distilled water were added to the test tube. After addition of
the sample to the FRAP reagent, a second reading at 593 nm
was performed after 4min. The changes in absorbance
after 4min from initial blank reading were compared with
standard curve, ferrous sulphate. Standards of known Fe
(II) concentrations were run using several concentrations
ranging from 200 to 1000 𝜇g/mL. A standard curve of FRAP
values of each standard versus its concentration was plotted.
The final result was expressed as mM ferric iron reduction to
ferrous iron in 1 g of dry sample (mM/g).
2.6.2. ABTS Decolourization Assay. The 2,2󸀠-azinobis(3-
ethylbenzothiazoline)-6-sulphonic acid or ABTS free radical
decolourization assay was done according to Re et al. [18]
with slight modifications. Working ABTS solution (7mM)
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and 2.45mM potassium persulfate were added to a beaker.
Themixture was allowed to stand for 15 h in the dark at room
temperature. The mixture was diluted with 80% methanol
to obtain the absorbance of 0.7 ± 0.02 units at 734 nm. An
aliquot of methanolic test solution of each sample (200 𝜇L)
was added to 2mL of ABTS free radical cation solution. It
was then vortex vigorously. The absorbance was measured
at 734 nm by using spectrophotometer. Standards of ascorbic
acid in the concentration ranging from 0 to 80𝜇g/mL were
run with the test samples, from which a standard curve was
plotted. The radical scavenging activity was expressed as mg
ascorbic acid equivalent antioxidant capacity in 1 g of dry
sample (mgAEAC/g).
2.6.3. DPPH Free Radical Scavenging Assay. The antioxidant
activity of the extract was measured by using 2,2-diphenyl-1-
pycrylhydrazyl (DPPH) as a free radical model and a method
adapted fromMensor et al. [19]. An aliquot (1mL) of 0.3mM
methanol solution of DPPH was added to 2.5mL sample
or standards. The solutions were mixed vigorously and left
to stand at room temperature for 30min in the dark. The
mixture wasmeasured spectrophotometrically at 518 nm.The
antioxidant activity (AA) was calculated as follows:
AA (%) = 100
− [
(Abs sample − Abs empty sample)
Abs control
]
× 100,
(1)
where Abs is the following absorbance:
Empty sample = 1mL methanol + 2.5mL extract,
Control sample = 1mL 0.3mMDPPH + 2.5mL
methanol.
Absorbance of empty sample is equal to the absorbance of
solvent added to extract without DPPH whereas absorbance
of sample is equal to the absorbance of extract added to
DPPH. The percentages of antioxidant activity of all samples
were plotted. The final results were expressed as IC
50
value
(the concentration of sample producing 50% scavenging of
the DPPH radical, 𝜇g/mL).
2.7. Cytotoxicity Study
2.7.1. Cell Culture. The hormone-dependent breast cancer
(MCF-7) and mouse embryonic fibroblast (3T3) cell lines
were obtained from American Type Culture Collection
(ATCC, USA) and were grown in RPMI 1640 media with L-
glutamine. Both cell lines were supplemented with 10% fetal
bovine serum and 1% penicillin-streptomycin and incubated
in CO
2
incubator at 37∘C.
2.7.2. MTT Assay. A method described by Abu Bakar et
al. [20] was referred for MTT assay. The cell viability was
determined by staining with trypan blue. Growing cells were
counted using haemocytometer and diluted in a culture
medium to a density of 1 × 106 cells/mL. From this cell
suspension, 100 𝜇L was pipetted using multichannel pipette
into 96-well microtitre plate and incubated at 37∘C overnight.
A serial dilution was added to each well of the plate starting
from row A to row H from a concentration of 100𝜇g/mL.
The plate was incubated for another 72 h. After that, 20𝜇L of
MTT reagent was added to each well and incubated for four
more hours. In order to dissolve and solubilize the coloured
crystals, 100𝜇L of solubilisation solution, dimethyl sulfoxide,
was added to each well. The absorbance was finally read
at 570 nm using ELISA reader (BMG LABTECH FLUOstar
Omega) from which the cytotoxicity was determined by the
following formula:
Cytotoxicity (%) =
Optical density of sample
Optical density of control
× 100. (2)
The inhibition concentration (IC
50
), concentration of extract
that is able to inhibit cell proliferation by 50%, was calculated
graphically for each cell proliferation curve.
2.7.3. Cell Cycle Analysis. The cell cycle analysis was done
according to method described by Abu Bakar et al. [20]. A
total of 1 × 106 cells were incubated and treated with the
sample extracts at IC
50
value for 24, 48, and 72 h. All adhering
and floating cells were harvested and transferred to a sterile
centrifuge tube. The cells were centrifuged using centrifuge
machine at 4∘C with 1,200 rpm for 10min. Cells were washed
using cold PBS and resuspended in 0.5mL cold PBS. Ice-cold
70% ethanol was added to the cell suspension and incubated
in −20∘C for 2 h. The sample was then centrifuged and the
ethanol was removed. The cells were washed twice using
cold PBS before they were stained with 500𝜇L of 10 𝜇g/mL
propidium iodide in 100 𝜇g/mL of RNase for 30min at room
temperature in the dark. Cell cycle distribution was detected
with flow cytometry.The results were analysed using Summit
4.3 software.
2.7.4. Annexin V-FITC Early and Late Apoptosis. The apopto-
sis was determined using Annexin V-FITC Apoptosis Detec-
tion Kit (Catalog Number APOAF, Sigma). Cells at a concen-
tration of 1 × 106 cells were incubated and treated with the
sample extracts at IC
50
value for 24, 48, and 72 h. All adhering
and floating cells were harvested, washed twice using PBS,
and transferred to a sterile centrifuge tube. The cells were
suspended in binding buffer (100mMHEPES/NaOH, pH 7.5
containing 1.4M NaCl and 25mM CaCl
2
) at a concentration
of 1 × 106 cells per mL. A total of 500 𝜇L of the cells were
transferred to a 5mL culture tube. After that, 5 𝜇L of Annexin
V-FITC conjugate and 10 𝜇L of propidium iodide were added
to the cell suspension. The cells were incubated for 10min at
room temperature in the dark. The fluorescence of the cells
was determined by flow cytometer. The results were analysed
using Summit 4.3 software.
2.7.5. Caspase-3 Activity Assay. The activity of caspase-3
was determined using Caspase-3 Colorimetric Assay Sample
Kit (Catalog Number BF3100, R & D Systems). Treated
and untreated cells with a total density of 1 × 106 were
harvested and transferred to a sterile test tube and lysed
using the cell lysis buffer provided. The lysed cells (50𝜇L)
were then aliquoted into 96-well microtitre plate. A reaction
buffer (50𝜇L) containing 10mM DTT was added. Substrates
selective (DEVD-pNA) were added to appropriate wells and
the plate was incubated at 37∘C for 2 h. The absorbance
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Table 1: Secondary metabolites of crude extract of 80% methanol of L. borneensis.
Number Retentiontime Compound name Concentration (%)
1 3.67 2-Propyn-1-ol 11.00
2 2.68 2-Propanone, 1-hydroxy- 9.93
3 58.00 2,2󸀠-Ethylenediphenol 6.49
4 12.60 1,3-Dioxol-2-one,4,5-dimethyl 4.78
5 7.99 1,2-Cyclopentanedione 4.41
6 15.05 2-Propenoic acid, ethyl ester 4.22
7 49.73 Hexadecanoic acid, methyl ester 2.85
8 7.01 2-Propanone, 1,3-dihydroxy- 2.56
9 3.28 Glycerin 2.52
10 6.38 Propanoic acid, 2-methyl-, methyl ester 2.31
11 64.65 cis-anti-cis-Tricyclo[7.3.0.0(2,6)]dodecan-7-one 2.03
12 52.71 𝛼-Patchoulene 1.82
13 21.28 2(3H)-Furanone, dihydro-5-pentyl- 1.76
14 30.45 Propanoic acid, 3-(acetyloxy)-2-(hydroxymethyl)-, ethyl ester, (+)- 1.59
15 67.20 Sandaracopimar-15-ene-6𝛽,8𝛽,11𝛼-triol 1.40
16 21.63 3-Hepten-2-one, 4-methyl- 1.32
17 55.73 Phytol 1.30
18 59.19 6𝛽 Bicyclo[4.3.0]nonane, 5𝛽-iodomethyl-1𝛽-isopropenyl-4𝛼,5𝛼dimethyl- 1.25
19 51.04 n-Hexadecanoic acid 1.05
20 37.04 Spathulenol 0.98
21 26.60 1,4-Butandiol, 2,3-dimethoxy- 0.94
22 56.89 Elemol 0.82
23 60.25 2-[4-Methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl]cyclohex-1-en-1-carboxaldehyde 0.77
24 61.67 2-[4-Methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl]cyclohex-1-en-1-carboxaldehyde 0.73
25 55.53 9,12,15-Octadecatrienoic acid, methyl ester, (Z,Z,Z)- 0.73
26 62.94 9,19-Cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, acetate, (3𝛽,4𝛼,5𝛼)- 0.72
27 64.85 4,8,13-Cyclotetradecatriene-1,3-diol, 1,5,9-trimethyl-12-(1-methylethyl)- 0.67
28 55.31 9,12-Octadecadienoic acid (Z,Z)-, methyl ester 0.58
29 59.63 11𝛼-Hydrozyresibufogenin 0.44
30 63.39 2-[4-Methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl]cyclohex-1-en-1-carboxaldehyde 0.37
31 65.07 Shyobunone 0.30
32 64.25 Spiro[2.5]octane, 5,5-dimethyl-4-(3-oxobutyl)- 0.26
33 50.08 Cycloheptane, 4-methylene-1-methyl-2-(2-methyl-1-propen-1-yl)-1-vinyl- 0.26
34 60.82 11𝛼-Hydrozyresibufogenin 0.25
35 67.75 Ethyl iso-allocholate 0.24
was finally read at a wavelength of 405 nm using microplate
reader.The absorbance of treated samples was comparedwith
untreated control for the determination of any fold increase
in caspase activity.
2.8. Statistical Analysis. All determinations were carried
out in three replicates in three independent experiments.
Results were expressed as mean ± standard deviation (SD).
Flow cytometry data (cell cycle and annexin-V FITC) and
caspase were analysed using Student’s 𝑡-test (unpaired).
𝑝-value < 0.05 was regarded as significant.
3. Results
3.1. Total Phenolic Contents (TPC), Total Flavonoid Contents
(TFC), andPhytochemical ProfilingUsingGC-MS. Theresults
showed that the total phenolic and flavonoid contents of 80%
methanol extract of L. borneensiswere 12.42± 0.47mgGAE/g
and 9.36 ± 1.29mgCE/g, respectively. The GC-MS analysis
revealed the presence of at least 35 compounds for L.
borneensis extract. The retention time taken by the bioactive
compounds of the sample extract varied from 2.68 to 67.75.
The list of bioactive compounds from the sample extract is
tabulated in Table 1.
3.2. Antioxidant Properties. For FRAP assay, the extract of L.
borneensis displayed high reducing ability with the value of
211.13 ± 0.89mM Fe2+/g. The extract of L. borneensis also has
the scavenging ability for ABTS assay with the value of 0.49
± 0.00mgAEAC/g whereas, for DPPH assay, the IC
50
value
was 216.67 ± 20.82𝜇g/mL.
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Figure 1: The effect of 80% methanol crude extract of L. borneensis on MCF-7 cell proliferation. Results are presented as mean ± standard
deviation (𝑛 = 3). Cells (1 × 106 cells/well) were treated with L. borneensis extract at different concentrations (0–100𝜇g/mL) for 72 h. Cell
proliferation was evaluated as the ability to reduce MTT to blue formazan crystals.
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Figure 2: Cell cycle distribution of MCF-7 cancer cells treated with 80% methanol crude extract of L. borneensis at IC
50
value. Values
are expressed as mean ± standard deviation (𝑛 = 3). ∗ showed a significant difference (𝑝 < 0.05) relative to their respective control. The
distribution of cells undergoing apoptosis and in various phases of the cell cycle was determined in MCF-7 cells treated with L. borneensis
extract for 24 h (a), 48 h (b), and 72 h (c) in comparison to their respective control.
3.3. Anticancer Properties. The results showed that the incu-
bation of crude extract of L. borneensis with MCF-7 cell
line inhibited cell proliferation with IC
50
value of 47.33 ±
7.37 𝜇g/mL. The extract of L. borneensis did not display
cytotoxic effect against 3T3 cell line. As illustrated in Figure 1,
the incubation of L. borneensis extract with MCF-7 cells
inhibited cell proliferation in a concentration dependent
manner in the concentration ranging from 20 to 100𝜇g/mL.
Apoptosis and cell cycle distribution in MCF-7 cells
were studied after exposure to L. borneensis extract at IC
50
concentration for 24, 48, and 72 hours (Figure 3). There was
a significant arrest at G
0
/G
1
for MCF-7 cell lines at 24 hours
of treatment with the crude extract of L. borneensis, whilst
the number of cells in S and G
2
-M phases were reduced
significantly (𝑝 < 0.05). After 48 hours of treatment, cells
were higher in S and G
2
-M phases as compared to their
respective control (𝑝 < 0.05). Apoptosis (sub-G
1
) occurred
in the first 24 hours of the experiment. After 48 and 72 hours
of treatment, the apoptosis phase had significantly increased
to 21.4% and 30.8% (𝑝 < 0.05), respectively. In addition to
this, the proportion of cells in G
0
/G
1
and G
2
-M phases had
decreased significantly as compared to their control after 72
hours of treatment (𝑝 < 0.05) (Figure 2).
There was a significant difference in the proportion of
cells that are undergoing early and late apoptosis detected
in cells treated with the crude extract of L. borneensis if
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Figure 3: Flow cytometric scans of untreated MCF-7 (a) cancer cells and those treated with 80% methanol crude extract of L. borneensis at
IC
50
value for 24 h (b), 48 h (c), and 72 h (d). Sectors P3–P6 represent the cells in sub-G
1
, G
0
/G
1
, S, and G
2
-M phases, respectively.
compared to control except for the late apoptosis for 48 hours
of treatment (𝑝 < 0.05) (Figure 4). The proportion of cells
in the live cell group decreased significantly from 2.4% for
24 hours treatment to 1.3% for 48 hours treatment with an
increase in the proportion of total cells in early and late
apoptosis from 54.7% for 24 hours treatment to 58.2% for 48
hours treatment. The total apoptosis increased up to 60.8%
(comprised of early apoptosis: 59.7% and late apoptosis: 1.1%)
at the end of 72 hours of treatment.
The activity of caspase 3 was evaluated in MCF-7 cells
to establish the cell death pathway induced by the extract of
L. borneensis. However, there was no activation of caspase
3 observed. The time course of effect of crude extract of
L. borneensis on the activity of the executioner caspase 3 is
shown in Figure 5.
4. Discussion
This species has not been extensively studied in terms of its
biological activities. This study reported the phytochemical
profiling as well as the antioxidants and antiproliferative
effects of L. borneensis extract against MCF-7 breast cancer
cell line.The antioxidant potential of this speciesmight be due
to the phytochemical contents by acting as reducing agents
or free radical scavengers and/or the synergistic effects by
phenolics and flavonoids [21]. It has been reported that the
biological activities of liverworts are due to the biological
characteristics of terpenoids and aromatic compounds they
possess [9]. The phytochemical contents of L. borneensis
extract is comparable to other extracts of liverworts species
such as methanol extract of Plagiochila beddomei (TPC =
19.3mg/g, TFC = 16.9mg/g) and ethanol extract ofMarchan-
tia polymorpha (TPC = 12.5mg/g) [21, 22]. Similar to the
extract of L. borneensis, both extracts also have the antioxi-
dant properties.
The GC-MS analysis of the L. borneensis extract showed
that 2-propyn-1-ol has the highest concentration among
detected secondary metabolites. In contrast to the result
of this study, a previous study showed that the major
compound of L. borneensis is 𝛽-bazzanene, a common
compound in Bazzania species which belong to the same
family of L. borneensis (Lepidoziaceae) [23, 24]. A recent
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Figure 4: Apoptosis study of MCF-7 cells treated with 80% methanol crude extract of L. borneensis at IC
50
value. Values are expressed as
mean ± standard deviation (𝑛 = 3). ∗ showed a significant difference (𝑝 < 0.05) relative to their respective control. The distribution of cells
undergoing early and late apoptosis together with those viable cells not in apoptosis and the total extent of apoptosis was determined in
MCF-7 cells treated with L. borneensis extract for 24 h (a), 48 h (b), and 72 h (c) in comparison to their respective control, using Annexin-V
FITC and propidium iodide flow cytometric analysis.
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Figure 5: Caspase-3 activity by 80% methanol crude extract of L.
borneensis. Values are expressed as mean ± standard deviation (𝑛 =
3).
study reported that 1,3-dioxol-2-one,4,5-dimethyl which
was also detected in Hedychium coronarium in vitro grown
stem extract (2.28%, RT: 5.66) has antihypertensive property
[25]. It was reported that the GC-qMS analysis revealed that
1,2-cyclopentanedione, a compound detected in L. borneensis
extract, is also one of the volatile metabolites detected in
Carica papaya [26]. Hexadecenoic acid was previously
reported to have antioxidant property [27].
In the present study, certain compounds detected in the
extract of L. borneensis were reported to have anticancer
properties. Acetol or 2-propanone, 1-hydroxy- was reported
to inhibit jack-bean urease activity with IC
50
value of 2.9mM
[28]. Other than acetol, phytol which was present in the
methanol extract of Cassia italica leaf (1.64%, RT: 18.47)
has anticancer, antimicrobial, cancer preventive, and anti-
inflammatory properties [27]. It has been suggested that the
synergistic effects of the crude extract might reflect the anti-
cancer property of sample extract [29]. Among flavonoids,
apigenin, epigallocatechin gallate, delphinidin, and genistein
have been stated as beneficial compounds in multistages
of carcinogenesis [30]. A study conducted on Marchantia
linearis showed that apigenin, quercetin, and luteolin are the
major flavonoids identified in the extract and the result of the
MTT assay showed that 50𝜇g/mL of flavonoid induced cell
proliferation as well as apoptosis in SW 480 colon cancer cell
lines [31].
The transition of G
1
to S phase requires a particular
protein [32]. The treatment of L. borneensis extract to MCF-
7 cells might alter the activity of this protein and caused
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cell cycle arrest in G
0
/G
1
phase and a parallel reduction in
G
2
phase. An increased number of cells in sub-G
1
indicated
apoptosis event [33]. Cell cycle arrest caused by the treatment
of L. borneensis extract might be associated with its phy-
tochemical compounds. Saponins, triterpenes, sterols, and
polyphenolic compounds were suggested to be responsible
for the cytotoxicity against cancer cell lines [34]. In a previous
study conducted on sasanquasaponin, a triterpenoid from
Camellia oleifera, it was found to induce G
1
cell cycle arrest
and apoptosis of MCF-7 cells [35]. Curcumin, a natural
polyphenol also induced G
1
cell cycle arrest in MCF-7 cell
line [36].
Therewas no induction of caspase 3 observedwhenMCF-
7 cells were exposed to L. borneensis extract. There might
be no involvement of caspase 8 or caspase 9 which will
lead to the activation of caspase 3 [37, 38]. Apoptosis might
occur using different pathways which omit the activation of
caspases. It was suggested that either caspase-activatedDNase
is activated by another enzyme or a caspase-independent
DNase is responsible for a DNA cleavage [39].
5. Conclusion
In conclusion, this study revealed that the extract of L.
borneensis displayed antioxidant properties and was able to
induce cell cycle arrest and apoptosis in hormone-dependent
breast cancer cells. Thus, this species has the potential to be
used as antioxidants and anticancer agents.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgments
The authors acknowledge the financial support provided
by the Ministry of Higher Education of Malaysia (MOHE)
under Exploratory Research Grant Scheme (ERGS) (Project
no. ERGS0028-STWN-1/2012) andUniversitiMalaysia Sabah
under UMS Research Grant Scheme (SGPUMS) (Project
no. SBK0019-STWN-1/2011). The authors would also like
to acknowledge Sabah Parks for the permission to enter
the study site areas for the purpose of sampling (Ref no.
S/PTD/5/4 Jld. 46 (63)). The authors are grateful to the
Institute for Tropical Biology and Conservation and Seaweed
Research Unit of Universiti Malaysia Sabah, Malaysia, and
Nutrition Laboratory of Faculty of Medicine and Health
Science of Universiti Putra Malaysia for the use of the
laboratory facilities and technical assistance.
References
[1] L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and
A. Jemal, “Global cancer statistics, 2012,” CA—ACancer Journal
for Clinicians, vol. 65, no. 2, pp. 87–108, 2015.
[2] M. Farooqui, M. A. Hassali, A. Knight et al., “A qualitative
exploration of Malaysian cancer patients’ perceptions of cancer
screening,” BMC Public Health, vol. 13, article 48, 2013.
[3] M. Farooqui, M. A. Hassali, A. Knight et al., “Cross sectional
assessment of health related quality of life (HRQoL) among
patientswith cancer inMalaysia,”AsianPacific Journal of Cancer
Prevention, vol. 14, no. 5, pp. 3017–3021, 2013.
[4] Y. K. Yong, J. J. Tan, S. S. Teh et al., “Clinacanthus nutans
extracts are antioxidant with antiproliferative effect on cultured
human cancer cell lines,” Evidence-Based Complementary and
Alternative Medicine, vol. 2013, Article ID 462751, 8 pages, 2013.
[5] J. A. Badmus, O. E. Ekpo, A. A. Hussein, M. Meyer, and D.
C. Hiss, “Antiproliferative and apoptosis induction potential of
the methanolic leaf extract ofHolarrhena floribunda (G. Don),”
Evidence-Based Complementary and Alternative Medicine, vol.
2015, Article ID 756482, 11 pages, 2015.
[6] M. Shoeb, “Anticancer agents from medicinal plants,”
Bangladesh Journal of Pharmacology, vol. 1, no. 2, pp. 35–
41, 2008.
[7] R. G. Bodade, P. S. Borkar, S. Arfeen, and C. N. Khobragade, “In
vitro screening of bryophytes for antimicrobial activity,” Journal
of Medicinal Plants, vol. 7, no. 4, pp. 23–28, 2008.
[8] F. Savaroglu, S. Ilhan, and C. Filik-Iscen, “An evaluation of
the antimicrobial activity of some Turkish mosses,” Journal of
Medicinal Plants Research, vol. 5, no. 14, pp. 3286–3292, 2011.
[9] Y. Asakawa, “Biologically active compounds from bryophytes,”
Pure and Applied Chemistry, vol. 79, no. 4, pp. 557–580, 2007.
[10] Y.Asakawa, “Recent advances in phytochemistry of bryophytes-
acetogenins, terpenoids and bis(bibenzyl)s from selected
Japanese, Taiwanese, New Zealand, Argentinean and European
liverworts,” Phytochemistry, vol. 56, no. 3, pp. 297–312, 2001.
[11] J. Gao, X. Li, B.-B. Lv, B. Sun, C.-J. Zhu, and H.-X. Lou, “LC-
DAD/MS/MS detection of macrocyclic bisbibenzyls from the
liverwort Reboulia hemisphaerica and the cell-based screening
of their microtubule inhibitory effects,” Chinese Journal of
Natural Medicines, vol. 7, no. 2, pp. 123–128, 2009.
[12] W.-J. Huang, C.-L. Wu, C.-W. Lin et al., “Marchantin A, a cyclic
bis(bibenzyl ether), isolated from the liverwort Marchantia
emarginata subsp. tosana induces apoptosis in human MCF-7
breast cancer cells,” Cancer Letters, vol. 291, no. 1, pp. 108–119,
2010.
[13] X. Xue, D.-F. Sun, C.-C. Sun et al., “Inhibitory effect of riccardin
D on growth of human non-small cell lung cancer: in vitro and
in vivo studies,” Lung Cancer, vol. 76, no. 3, pp. 300–308, 2012.
[14] D.Wang, R.-L. Zhu, andL.Qu, “Antibacterial activity in extracts
of Cylindrocolea recurvifolia (Cephaloziellaceae, Marchantio-
phyta) and Pleurozia subinflata (Pleuroziaceae, Marchantio-
phyta),” Cryptogamie, Bryologie, vol. 27, no. 3, pp. 343–348,
2006.
[15] Y. S. Velioglu, G.Mazza, L. Gao, and B. D. Oomah, “Antioxidant
activity and total phenolics in selected fruits, vegetables, and
grain products,” Journal of Agricultural and Food Chemistry, vol.
46, no. 10, pp. 4113–4117, 1998.
[16] J. Zhishen, T.Mengcheng, andW. Jianming, “Thedetermination
of flavonoid contents in mulberry and their scavenging effects
on superoxide radicals,” Food Chemistry, vol. 64, no. 4, pp. 555–
559, 1999.
[17] I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of
plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP
assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996.
Evidence-Based Complementary and Alternative Medicine 9
[18] R. Re, N. Pellegrini, A. Proteggente, A. Pannala,M. Yang, andC.
Rice-Evans, “Antioxidant activity applying an improved ABTS
radical cation decolorization assay,” Free Radical Biology &
Medicine, vol. 26, no. 9-10, pp. 1231–1237, 1999.
[19] L. L. Mensor, F. S. Menezes, G. G. Leita˜o et al., “Screening of
Brazilian plant extracts for antioxidant activity by the use of
DPPH free radical method,” Phytotherapy Research, vol. 15, no.
2, pp. 127–130, 2001.
[20] M. F. Abu Bakar, M. Mohamad, A. Rahmat, S. A. Burr, and J.
R. Fry, “Cytotoxicity, cell cycle arrest, and apoptosis in breast
cancer cell lines exposed to an extract of the seed kernel of
Mangifera pajang (bambangan),”Food andChemical Toxicology,
vol. 48, no. 6, pp. 1688–1697, 2010.
[21] G. S. Manoj and K. Murugan, “Wound healing potential of
aqueous and methanolic extracts of Plagiochila beddomei
steph.—a bryophyte,” International Journal of Pharmacy and
Pharmaceutical Sciences, vol. 4, no. 2, pp. 222–227, 2012.
[22] R. Krishnan and K. Murugan, “Polyphenols from Marchantia
polymorpha L. A bryophyta: a potential source as antioxidants,”
World Journal of Pharmacy and Pharmaceutical Sciences, vol. 2,
no. 6, pp. 5182–5198, 2013.
[23] A. Ludwiczuk and Y. Asakawa, “Chemosystematics of selected
liverworts collected in Borneo,” Bryophyte Diversity and Evolu-
tion, vol. 31, no. 1, pp. 33–42, 2010.
[24] Y. Asakawa, X. Lin, K. Kondo, and Y. Fukuyama, “Terpenoids
and aromatic compounds from selected East Malaysian liver-
worts,” Phytochemistry, vol. 30, no. 12, pp. 4019–4024, 1991.
[25] M. Verma and Y. K. Bansal, “Screening and evaluation of
bioactive components of Hedychium coronarium J. Koenig in
nature grown and in vitro regenerated plants by gc-ms analysis,”
World Journal of Pharmacy and Pharmaceutical Sciences, vol. 4,
no. 4, pp. 1729–1747, 2015.
[26] J. Pereira, J. Pereira, and J. S. Caˆmara, “Effectiveness of different
solid-phasemicroextraction fibres for differentiation of selected
Madeira island fruits based on their volatilemetabolite profile—
identification of novel compounds,” Talanta, vol. 83, no. 3, pp.
899–906, 2011.
[27] M. Sermakkani and V. Thangapandian, “GC-MS analysis of
Cassia italica leaf methanol extract,” Asian Journal of Pharma-
ceutical and Clinical Research, vol. 5, no. 2, pp. 90–94, 2012.
[28] T. Tanaka, M. Kawase, and S. Tani, “𝛼-Hydroxyketones as
inhibitors of urease,” Bioorganic and Medicinal Chemistry, vol.
12, no. 2, pp. 501–505, 2004.
[29] M. F. Abu Bakar, M. Mohamed, A. Rahmat, S. A. Burr, and
J. R. Fry, “Cytotoxicity and polyphenol diversity in selected
parts ofMangifera pajang and Artocarpus odoratissimus fruits,”
Nutrition & Food Science, vol. 40, no. 6, pp. 29–38, 2010.
[30] N. Clere, S. Faure, M. C. Martinez, and R. Andriantsitohaina,
“Anticancer properties of flavonoids: roles in various stages
of carcinogenesis,” Cardiovascular & Hematological Agents in
Medicinal Chemistry, vol. 9, no. 2, pp. 62–77, 2011.
[31] R. Krishnan and K. Murugan, “In vitro anticancer properties of
flavonoids extracted from cell suspension culture ofMarchantia
linearis Lehm & Lindenb. (Bryophyta) against SW 480 colon
cancer cell lines,” Indo American Journal of Pharmaceutical
Research, vol. 3, no. 12, pp. 1427–1437, 2013.
[32] M.K.Diril, C. K. Ratnacaram,V.C. Padmakumar et al., “Cyclin-
dependent kinase 1 (Cdk1) is essential for cell division and sup-
pression of DNA re-replication but not for liver regeneration,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 109, no. 10, pp. 3826–3831, 2012.
[33] J. B. Foo, L. S. Yazan, K. W. Chan, P. M. Tahir, and M.
Ismail, “Kenaf seed oil from supercritical carbon dioxide fluid
extraction induced G1 phase cell cycle arrest and apoptosis in
leukemia cells,” African Journal of Biotechnology, vol. 10, no. 27,
pp. 5389–5397, 2011.
[34] N. Armania, L. S. Yazan, I. S. Ismail et al., “Dillenia suffruticosa
extract inhibits proliferation of human breast cancer cell lines
(MCF-7 and MDA-MB-231) via Induction of G
2
/M arrest and
apoptosis,”Molecules, vol. 18, no. 11, pp. 13320–13339, 2013.
[35] L. Chen, J. Chen, and H. Xu, “Sasanquasaponin from Camellia
oleifera Abel. induces cell cycle arrest and apoptosis in human
breast cancer MCF-7 cells,” Fitoterapia, vol. 84, no. 1, pp. 123–
129, 2013.
[36] H. Q. Li, L. J. Jin, F. F. Wu et al., “Effect of curcumin on
proliferation, cell cycle, and caspases and MCF 7 cells,” African
Journal of Pharmacy and Pharmacology, vol. 6, no. 12, pp. 864–
870, 2012.
[37] H. A. Harrington, K. L. Ho, S. Ghosh, and K. Tung, “Construc-
tion and analysis of a modular model of caspase activation in
apoptosis,”Theoretical Biology andMedical Modelling, vol. 5, pp.
26–40, 2008.
[38] S. Snigdha, E. D. Smith, G. A. Prieto, and C. W. Cotman,
“Caspase-3 activation as a bifurcation point between plasticity
and cell death,” Neuroscience Bulletin, vol. 28, no. 1, pp. 14–24,
2012.
[39] D. G. Fujikawa, X. Ke, R. B. Trinidad, S. S. Shinmei, and A.
Wu, “Caspase-3 is not activated in seizure-induced neuronal
necrosis with intemucleosomal DNA cleavage,” Journal of Neu-
rochemistry, vol. 83, no. 1, pp. 229–240, 2002.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
